A clinical trials agenda for testing interventions in earlier stages of psychotic disorders

Area of Science:

• Psychiatry and Clinical Psychology
• Mental Health Research
• Neuroscience

Background:

• Current clinical trial designs for psychotic disorders require significant updates.
• There is a need to evaluate interventions across various illness stages.
• Traditional treatments should be complemented by novel strategies.

Purpose of the Study:

• To propose a fundamental shift in clinical trial design for psychotic disorders.
• To emphasize the evaluation of interventions targeting different phases of illness.
• To introduce a new national clinical trials platform for youth mental health.

Main Methods:

• The study outlines a conceptual framework for redesigned clinical trials.
• It advocates for integrating informational, e-health, behavioral, and neuroprotective strategies.
• A new national clinical trials platform, based on headspace, is proposed.

Main Results:

• The proposed shift is deemed both desirable and feasible.
• The new platform offers opportunities for large-scale, multisite trials.
• Focus on emerging mental disorders in young people is highlighted.

Conclusions:

• A redesigned approach to clinical trials for psychotic disorders is essential.
• Integrating diverse therapeutic strategies and leveraging a national platform can advance research.
• Early intervention and trials in young populations are critical for improving outcomes.